Kromek Group (KMK) H2 2026 TU earnings summary

Executive summary

• Revenues and profit before tax (PBT) for FY26 are expected to be in line with market expectations, reflecting resilience and strong customer relationships.

• Both CBRN Detection and Advanced Imaging divisions achieved operational and commercial progress, with new orders totaling £8.8m in H2, much of which was delivered before year end.

• The business model and technology remain relevant in mission-critical applications, supporting continued momentum into the next fiscal year.

Financial highlights

• FY26 consensus estimates are revenues of £27.2 million and PBT of £2.15 million.

• Increased revenue in the CBRN Detection division and underlying growth in Advanced Imaging, excluding the exceptional Siemens Healthineers agreement.

Outlook and guidance

• The Group remains focused on executing strategic priorities and expects to report further progress at the full year results announcement in September 2026.